About Cour Pharma
Cour Pharma is a company based in Chicago (United States) founded in 2013.. Cour Pharma has raised $135.2 million across 6 funding rounds from investors including Pfizer, Roche and Bristol-Myers Squibb. The company has 31 employees as of December 31, 2021. Cour Pharma offers products and services including CNP-103 and CNP-106. Cour Pharma operates in a competitive market with competitors including Moderna, BeiGene, Biogen, Incyte and ADMA Biologics, among others.
- Headquarter Chicago, United States
- Employees 31 as on 31 Dec, 2021
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$135.2 M (USD)
in 6 rounds
-
Latest Funding Round
$105 M (USD), Series A
Jan 30, 2024
-
Investors
Pfizer
& 6 more
-
Employee Count
31
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cour Pharma
Cour Pharma offers a comprehensive portfolio of products and services, including CNP-103 and CNP-106. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Therapy to induce tolerance for type 1 diabetes using nanoparticles
Treatment for myasthenia gravis via immune-modifying nanoparticles
Unlock access to complete
Unlock access to complete
Funding Insights of Cour Pharma
Cour Pharma has successfully raised a total of $135.2M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $105 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $105.0M
-
First Round
First Round
(28 Jan 2013)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Series A - Cour Pharma | Valuation | Lumira Ventures , Roche | |
| Sep, 2022 | Amount | Series A - Cour Pharma | Valuation | Alpha Wave Global |
|
| Jan, 2016 | Amount | Seed - Cour Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cour Pharma
Cour Pharma has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, Roche and Bristol-Myers Squibb. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Lumira Ventures is engaged in life sciences venture capital investment.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on growth-stage companies
|
Founded Year | Domain | Location | |
|
Angelini Ventures is focused on investing in BioTech and Digital Health.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cour Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cour Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cour Pharma Comparisons
Competitors of Cour Pharma
Cour Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BeiGene, Biogen, Incyte and ADMA Biologics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Plasma-based biologics are developed for immune deficiency and infectious diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutic antibodies for cancer and other diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cour Pharma
Frequently Asked Questions about Cour Pharma
When was Cour Pharma founded?
Cour Pharma was founded in 2013.
Where is Cour Pharma located?
Cour Pharma is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Is Cour Pharma a funded company?
Cour Pharma is a funded company, having raised a total of $135.2M across 6 funding rounds to date. The company's 1st funding round was a Seed of $169.25K, raised on Jan 28, 2013.
How many employees does Cour Pharma have?
As of Dec 31, 2021, the latest employee count at Cour Pharma is 31.
What does Cour Pharma do?
Cour Pharma was founded in 2013 and is based in Chicago, United States. Operations focus on the biotechnology sector, where proprietary nanoparticle platforms are utilized for immune-related conditions. Immune Modifying Nanoparticles target severe inflammations by binding to monocytes for elimination, while Tolerizing Immune Modifying Nanoparticles introduce antigens to reprogram the immune system against autoimmune and allergic disorders. The nanoparticles consist of an FDA-approved biodegradable copolymer.
Who are the top competitors of Cour Pharma?
Cour Pharma's top competitors include Moderna, BeiGene and ADMA Biologics.
What products or services does Cour Pharma offer?
Cour Pharma offers CNP-103 and CNP-106.
Who are Cour Pharma's investors?
Cour Pharma has 7 investors. Key investors include Pfizer, Roche, Bristol-Myers Squibb, Lumira Ventures, and Alpha Wave Global.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.